SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-23-097774
Filing Date
2023-12-22
Accepted
2023-12-21 19:22:37
Documents
6
Effectiveness Date
2023-12-22

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea190385-s8_inmedpharma.htm S-8 43870
2 OPINION OF NORTON ROSE FULBRIGHT CANADA LLP REGARDING LEGALITY OF SECURITIES BEI ea190385ex5-1_inmed.htm EX-5.1 13227
3 CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea190385ex23-1_inmed.htm EX-23.1 2223
4 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea190385ex23-2_inmed.htm EX-23.2 2309
5 FILING FEE TABLE ea190385ex-fee_inmed.htm EX-FILING FEES 9573
6 GRAPHIC ex5-1_001.jpg GRAPHIC 4019
  Complete submission text file 0001213900-23-097774.txt   77930
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-276212 | Film No.: 231506827
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)